ACLY
-
BMS303141
Catalog No. A13807 ATP-citrate lyase inhibitorBMS303141 is a potent inhibitor of ATP citrate lyase (ACL). BMS303141 inhibits lipid synthesis in HepG2 cells with an IC50 of 8 μM, and lowers plasma triglycerides in a murine hyperlipdemia model. Learn More -
ETC-1002
Catalog No. A15815 ACL inhibitor and AMPK activatorETC-1002 is a novel, first-in-class, orally available, once-daily LDL-C lowering small molecule; activator of hepatic AMP-activated protein kinase (AMPK); also has potent inhibitory activity against hepatic ATP-citrate lyase(IC50=29 uM). Learn More